Get started
Author

Maximilian F. Konig

Observed names: M F Konig, M. Konig, M.F. Konig, Maximilian F Koenig, Maximilian F Konig, Maximilian F König, Maximilian Ferdinand Konig, Maximilian Konig, Maximillian F Konig, Maximillian F. Konig
Observed institutions: Howard Hughes Medical Institute, Harvard University, Johns Hopkins University, Johns Hopkins Medicine, Lustgarten Foundation, Massachusetts General Hospital, Johns Hopkins Hospital, Sidney Kimmel Comprehensive Cancer Center
ORCID: 0000-0001-5045-5255
Observed ORCID: 0000-0001-5045-5255
OpenAlex ID: A5048442212
Aggregatibacter actinomycetemcomitans –induced hypercitrullination links periodontal infection to autoimmunity in rheumatoid arthritis
2016 · Maximilian F. Konig, Loreto Abusleme, et al. · Science Translational Medicine · 588
PDF
Targeting a neoantigen derived from a common TP53 mutation
2021 · Emily Han-Chung Hsiue, Katharine M. Wright, et al. · Science · 357
Cancer therapy with antibodies
2024 · Suman Paul, Maximilian F. Konig, et al. · Nature reviews. Cancer · 249
PDF
A Critical Reappraisal of Neutrophil Extracellular Traps and NETosis Mimics Based on Differential Requirements for Protein Citrullination
2016 · Maximilian F. Konig, Felipe Andrade · Frontiers in Immunology · 241
PDF
Targeting public neoantigens for cancer immunotherapy
2021 · Alexander H. Pearlman, Michael S. Hwang, et al. · Nature Cancer · 187
SARS – CoV ‐2 Infection and COVID ‐19 Outcomes in Rheumatic Diseases: A Systematic Literature Review and Meta‐Analysis
2021 · Richard Conway, Alyssa A. Grimshaw, et al. · Arthritis & Rheumatology · 178
PDF
Bispecific antibodies targeting mutant RAS neoantigens
2021 · Jacqueline Douglass, Emily Han-Chung Hsiue, et al. · Science Immunology · 168
Preventing cytokine storm syndrome in COVID-19 using α-1 adrenergic receptor antagonists
2020 · Maximilian F. Konig, Mike Powell, et al. · Journal of Clinical Investigation · 112
PDF
Defining the role of Porphyromonas gingivalis peptidylarginine deiminase (PPAD) in rheumatoid arthritis through the study of PPAD biology
2014 · Maximilian F Konig, Alizay S Paracha, et al. · Annals of the Rheumatic Diseases · 107
The microbiome in autoimmune rheumatic disease
2020 · Maximilian F. Konig · Best Practice & Research Clinical Rheumatology · 88
Baseline use of hydroxychloroquine in systemic lupus erythematosus does not preclude SARS-CoV-2 infection and severe COVID-19
2020 · Maximilian F Konig, Alfred HJ Kim, et al. · Annals of the Rheumatic Diseases · 83
Targeting loss of heterozygosity for cancer-specific immunotherapy
2021 · Michael S. Hwang, Brian J. Mog, et al. · Proceedings of the National Academy of Sciences · 74
Swinging the pendulum: lessons learned from public discourse concerning hydroxychloroquine and COVID-19
2020 · Sebastian E. Sattui, Jean W. Liew, et al. · Expert Review of Clinical Immunology · 69
Association of Higher Hydroxychloroquine Blood Levels With Reduced Thrombosis Risk in Systemic Lupus Erythematosus
2021 · Michelle Petri, Maximilian F. Konig, et al. · Arthritis & Rheumatology · 65
TCR β chain–directed bispecific antibodies for the treatment of T cell cancers
2021 · Suman Paul, Alexander H. Pearlman, et al. · Science Translational Medicine · 58
Antibodies to native and citrullinated RA33 (hnRNP A2/B1) challenge citrullination as the inciting principle underlying loss of tolerance in rheumatoid arthritis
2016 · Maximilian F Konig, Jon T Giles, et al. · Annals of the Rheumatic Diseases · 58
Rheumatoid Arthritis-Associated Autoimmunity Due to Aggregatibacter actinomycetemcomitans and Its Resolution With Antibiotic Therapy
2018 · Amarshi Mukherjee, Vanessa Jantsch, et al. · Frontiers in Immunology · 57
PDF
Immediate effect of the COVID-19 pandemic on patient health, health-care use, and behaviours: results from an international survey of people with rheumatic diseases
2021 · Jonathan S Hausmann, Kevin Kennedy, et al. · The Lancet Rheumatology · 52
PDF
Improving the sensitivity of in vivo CRISPR off-target detection with DISCOVER-Seq+
2023 · Roger S. Zou, Yang Liu, et al. · Nature Methods · 51
PDF
TRBC1-targeting antibody–drug conjugates for the treatment of T cell cancers
2024 · Tushar D. Nichakawade, Jiaxin Ge, et al. · Nature · 45
PDF
Autoantibodies to Peptidylarginine Deiminase 2 Are Associated With Less Severe Disease in Rheumatoid Arthritis
2018 · Erika Darrah, Jon T. Giles, et al. · Frontiers in Immunology · 45
PDF
Sarcoidosis and autoimmune diseases
2018 · Peter Korsten, Björn Tampe, et al. · Current Opinion in Pulmonary Medicine · 44
Festina lente: hydroxychloroquine, COVID-19 and the role of the rheumatologist
2020 · Elizabeth R Graef, Jean W Liew, et al. · Annals of the Rheumatic Diseases · 43
Proteinase 3-specific antineutrophil cytoplasmic antibody-associated vasculitis
2024 · Samuel D Falde, Lynn A Fussner, et al. · The Lancet Rheumatology · 39
Structural engineering of chimeric antigen receptors targeting HLA-restricted neoantigens
2021 · Michael S. Hwang, Michelle S. Miller, et al. · Nature Communications · 38
PDF
Works count: 99
Citation count: 3,739
H-index: 31
I10-index: 49
Year
Topic
Type